Career records & work history
Medicine Doctors
Yan Xiong
Specialties:
Internal Medicine
Yan Xiong, 4231 Hadrian Dr, Livingston, NJ 07039
Yan Xiong Phones & Addresses
Livingston, NJ
Short Hills, NJ
20 Newport Pkwy APT 615, Jersey City, NJ 07310
Ponce, PR
Metuchen, NJ
Piscataway, NJ
Harrison, NJ
35 River Dr S APT 1614, Jersey City, NJ 07310
Mentions for Yan Xiong
Yan Xiong resumes & CV records
Resumes
Software Engineer At Ask.com
Location:
Greater New York City Area
Industry:
Computer Software
Yan Xiong
Yan Xiong
Yan Xiong
Yan Xiong
Location:
United States
Publications & IP owners
Wikipedia
Xig Yan
Xiong Yan () is a Chinese dissident who served as a chaplain in U.S. Army in Iraq. Currently, he serves as a U.S. Army chaplain at the Warrant Officer ...
Us Patents
Protein Tyrosine Kinase 6 (Ptk6) Degradation / Disruption Compounds And Methods Of Use
US Patent:
2023007, Mar 9, 2023
Filed:
Jul 3, 2019
Appl. No.:
17/256516
Inventors:
- New York NY, US
Hanna Irie - New York NY, US
Jing Liu - New York NY, US
Yan Xiong - New York NY, US
Jessica Byerly - New York NY, US
Shannon Tomita - New York NY, US
Jianping Hu - New York NY, US
Hanna Irie - New York NY, US
Jing Liu - New York NY, US
Yan Xiong - New York NY, US
Jessica Byerly - New York NY, US
Shannon Tomita - New York NY, US
Jianping Hu - New York NY, US
International Classification:
A61K 47/54
A61P 35/00
A61K 45/06
A61P 35/00
A61K 45/06
Abstract:
Disclosed herein are protein tyrosine kinase 6 (PTK6) degradation/disruption compounds including a PTK6 ligand, a N degradation/disruption tag, and a linker, and methods of using such compounds in the treatment of FTK6-mediated diseases.
Joint Transmission Commitment Simulation
US Patent:
2021029, Sep 23, 2021
Filed:
Dec 20, 2017
Appl. No.:
16/605566
Inventors:
- Mountain View CA, US
Nitish J. Korula - New York NY, US
Martin Blais - New York NY, US
Michael Sobin - New York NY, US
Son Ba Nguyen - Jersey City NJ, US
Yan Xiong - Jersey City NJ, US
Nitish J. Korula - New York NY, US
Martin Blais - New York NY, US
Michael Sobin - New York NY, US
Son Ba Nguyen - Jersey City NJ, US
Yan Xiong - Jersey City NJ, US
International Classification:
G06F 9/50
G06F 9/46
G06F 9/46
Abstract:
Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for performing a joint simulation for satisfying multiple different coexisting commitments to allocate digital resources. In one aspect, a method includes accessing logged data for prior allocations of digital resources, where the logged data includes at least one property associated with respective allocations of the digital resources. Different allocations of the digital resources included in the logged data are assigned to different ones of the multiple different commitments. For each commitment to allocate digital resources, an expected required resource amount that results in the commitment being allocated at least a specified minimum resource based on the allocations of digital resources of the logged data that were assigned to the multiple different commitments is determined.
3D-Organized Nanomaterials Through Dna-Prescribed And Valence-Controlled Material
US Patent:
2021026, Aug 26, 2021
Filed:
Oct 14, 2020
Appl. No.:
17/070643
Inventors:
- New York NY, US
Ye Tian - Nanjing, CN
Jason S. Kahn - New York NY, US
Yan Xiong - New York NY, US
Brian Minevich - New York NY, US
Sanat K. Kumar - New York NY, US
Ye Tian - Nanjing, CN
Jason S. Kahn - New York NY, US
Yan Xiong - New York NY, US
Brian Minevich - New York NY, US
Sanat K. Kumar - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
G06T 17/00
Abstract:
The present subject matter relates to a voxel and methods of organizing an object into a three-dimensional (3D) array using the voxel. The voxel can include a plurality of frames including at least one single stranded (ss) DNA motif with at least one free base, wherein the at least one ssDNA motif hybridizes with a complementary strand fragment of other frames.
Compositions And Methods For Treating Cdk4/6-Mediated Cancer
US Patent:
2019033, Nov 7, 2019
Filed:
Dec 7, 2017
Appl. No.:
16/467888
Inventors:
- New York NY, US
Xiaobao Yang - New York NY, US
Jing Liu - Oradell NJ, US
Yan Xiong - New York NY, US
Poulikos Poulikakos - New York NY, US
Zoi Karoulia - New York NY, US
Xuewei Wu - New York NY, US
Tamer Ahmed - Edison NJ, US
Xiaobao Yang - New York NY, US
Jing Liu - Oradell NJ, US
Yan Xiong - New York NY, US
Poulikos Poulikakos - New York NY, US
Zoi Karoulia - New York NY, US
Xuewei Wu - New York NY, US
Tamer Ahmed - Edison NJ, US
International Classification:
A61K 31/506
A61K 45/06
A61K 47/55
A61P 35/00
A61K 31/519
A61K 45/06
A61K 47/55
A61P 35/00
A61K 31/519
Abstract:
Methods for designing heterobifunctional small molecules which selectively degrade/disrupt CDK4/6 and compositions and methods of using such degraders/disruptors to treat CDK4/6-mediated cancer are provided.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.